Turning tumors from cold to inflamed to improve immunotherapy response
Gerard, C.L., Delyon, J., Wicky, A., Homicsko, K., Cuendet, Michel A., Michielin, O.
Published in Cancer treatment reviews (01.12.2021)
Published in Cancer treatment reviews (01.12.2021)
Get full text
Journal Article
Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival
Delyon, J., Mateus, C., Lefeuvre, D., Lanoy, E., Zitvogel, L., Chaput, N., Roy, S., Eggermont, A.M.M., Routier, E., Robert, C.
Published in Annals of oncology (01.06.2013)
Published in Annals of oncology (01.06.2013)
Get full text
Journal Article
PD-1 blockade with nivolumab in endemic Kaposi sarcoma
Delyon, J., Bizot, A., Battistella, M., Madelaine, I., Vercellino, L., Lebbé, C.
Published in Annals of oncology (01.04.2018)
Published in Annals of oncology (01.04.2018)
Get full text
Journal Article
Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy
Ghisoni, E., Wicky, A., Bouchaab, H., Imbimbo, M., Delyon, J., Gautron Moura, B., Gérard, C.L., Latifyan, S., Özdemir, B.C., Caikovski, M., Pradervand, S., Tavazzi, E., Gatta, R., Marandino, L., Valabrega, G., Aglietta, M., Obeid, M., Homicsko, K., Mederos Alfonso, N.N., Zimmermann, S., Coukos, G., Peters, S., Cuendet, M.A., Di Maio, M., Michielin, O.
Published in European journal of cancer (1990) (01.05.2021)
Published in European journal of cancer (1990) (01.05.2021)
Get full text
Journal Article
Acquired generalized lipodystrophy under immune checkpoint inhibition
Haddad, N., Vidal‐Trecan, T., Baroudjian, B., Zagdanski, A.‐M., Arangalage, D., Battistella, M., Gautier, J.‐F., Lebbe, C., Delyon, J.
Published in British journal of dermatology (1951) (01.02.2020)
Published in British journal of dermatology (1951) (01.02.2020)
Get full text
Journal Article
Dabrafenib and trametinib exposure-efficacy and tolerance in metastatic melanoma patients: a pharmacokinetic–pharmacodynamic real-life study
Goldwirt, Lauriane, Louveau, B., Baroudjian, B., Allayous, C., Jouenne, F., Da Meda, L., Vu, L.-T., Sauvageon, H., Herms, F., Delyon, J., Lebbé, C., Mourah, S.
Published in Cancer chemotherapy and pharmacology (01.09.2021)
Published in Cancer chemotherapy and pharmacology (01.09.2021)
Get full text
Journal Article
PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma
Delyon, J, Servy, A, Laugier, F, André, J, Ortonne, N, Battistella, M, Mourah, S, Bensussan, A, Lebbé, C, Dumaz, N
Published in Oncogene (08.06.2017)
Published in Oncogene (08.06.2017)
Get full text
Journal Article
Clinical response to immune checkpoint inhibition in patients with advanced skin cancers receiving concurrent ruxolitinib therapy for haematological malignancy
Haddad, N., Delyon, J., Trabelsi Messai, S., Herms, F., Leccia, M.T., Lebbe, C., Whitney, J., Bhatia, S., Basset‐Seguin, N.
Published in British journal of dermatology (1951) (01.03.2021)
Published in British journal of dermatology (1951) (01.03.2021)
Get full text
Journal Article
Clinical significance of BRAF/NRAS concurrent mutations in a clinic‐based metastatic melanoma cohort
Regno, L., Louveau, B., Battistella, M., Sadoux, A., Baroudjian, B., Delyon, J., Serror, K., Allayous, C., Lebbe, C., Mourah, S., Jouenne, F.
Published in British journal of dermatology (1951) (01.05.2020)
Published in British journal of dermatology (1951) (01.05.2020)
Get full text
Journal Article
Efficacy and safety of brentuximab vedotin plus bendamustine in advanced‐stage primary cutaneous T‐cell lymphomas
Dumont, M., Ram‐Wolff, C., Roelens, M., Brice, P., Peffault de Latour, R., Battistella, M., Madelaine, I., Delyon, J., Herms, F., Bouaziz, J.‐D., Moins‐Teisserenc, H., Lebbé, C., Bagot, M., Masson, A.
Published in British journal of dermatology (1951) (01.12.2019)
Published in British journal of dermatology (1951) (01.12.2019)
Get full text
Journal Article
Cutaneous manifestations revealing cryofibrinogenaemia associated with monoclonal gammopathy
Delyon, J, Bezier, M, Cordoliani, F, Malphettes, M, Szalat, R, Bagot, M, Rybojad, M
Published in Annales de dermatologie et de vénéréologie (01.01.2013)
Published in Annales de dermatologie et de vénéréologie (01.01.2013)
Get full text
Journal Article
490 The role of PDE4D in resistance to targeted therapy in melanoma
Roger, A., Becherirat, S., Delyon, J., Andre, J., Lebbe, C., Dumaz, N.
Published in Journal of investigative dermatology (01.09.2019)
Published in Journal of investigative dermatology (01.09.2019)
Get full text
Journal Article
Management of Kaposi sarcoma after solid organ transplantation: A European retrospective study
Delyon, Julie, Rabate, Clementine, Euvrard, Sylvie, Harwood, Catherine A., Proby, Charlotte, Güleç, A.Tülin, Seçkin, Deniz, Del Marmol, Veronique, Bouwes-Bavinck, Jan Nico, Ferrándiz-Pulido, Carla, Ocampo, Maria Andrea, Barete, Stephane, Legendre, Christophe, Francès, Camille, Porcher, Raphael, Lebbe, Celeste
Published in Journal of the American Academy of Dermatology (01.08.2019)
Published in Journal of the American Academy of Dermatology (01.08.2019)
Get full text
Journal Article
Cochleovestibular toxicity induced by immune checkpoint inhibition: a case series
Lemasson, Juliette, Cuzzubbo, Stefania, Doucet, Ludovic, Gounant, Valérie, Baroudjian, Barouyr, Herms, Florian, Carpentier, Antoine F., Lebbé, Céleste, Vitaux, Hélène, Hautefort, Charlotte, Delyon, Julie
Published in European journal of cancer (1990) (01.08.2019)
Published in European journal of cancer (1990) (01.08.2019)
Get full text
Journal Article
1685PClinical course and therapeutic management of classical and endemic Kaposi’s Sarcoma (C/E KS)
Benajiba, L, Lambert, J, La Selva, R, Cochereau, D, Baroudjian, B, Roux, J, Basset-Seguin, N, Laurent, C Pages, Battistella, M, Delyon, J, Lebbe, C
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Long-term outcome of neoadjuvant tyrosine kinase inhibitors (TKI) in locally advanced dermatofibrosarcoma protuberans (DFSP)
Beaziz, J., Battistella, M., Delyon, J., Maignan, C Le, Marco, O., Kérob, D., Laurent, C Pages, Da Meda, L., Farges, C., Basset-Seguin, N., Lebbe, C., Baroudjian, B.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1703PLong-term outcome of neoadjuvant tyrosine kinase inhibitors (TKI) in locally advanced dermatofibrosarcoma protuberans (DFSP)
Beaziz, J, Battistella, M, Delyon, J, Maignan, C Le, Marco, O, Kérob, D, Laurent, C Pages, Da Meda, L, Farges, C, Basset-Seguin, N, Lebbe, C, Baroudjian, B
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1685P - Clinical course and therapeutic management of classical and endemic Kaposi’s Sarcoma (C/E KS)
Benajiba, L., Lambert, J., La Selva, R., Cochereau, D., Baroudjian, B., Roux, J., Basset-Seguin, N., Laurent, C Pages, Battistella, M., Delyon, J., Lebbe, C.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article